Corpus Intelligence IC Memo — SPECIALTY HOSPITAL OF LORAIN 2026-04-26 13:47 UTC
IC Memo — SPECIALTY HOSPITAL OF LORAIN
Investment Committee Memorandum | OH | 24 beds | Grade D | EBITDA uplift $472K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SPECIALTY HOSPITAL OF LORAIN

CCN 362025 | LORAIN, OH | 24 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

SPECIALTY HOSPITAL OF LORAIN is a 24-bed safety-net/medicaid heavy in LORAIN, OH with $6.3M in net patient revenue and a -1.6% operating margin. The hospital serves a payer mix of 45.7% Medicare, 32.6% Medicaid, and 21.7% commercial.

Thesis: Turnaround. Our ML models identify $472K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.6% to 5.9% (+753bps).

Net Revenue HCRIS$6.3M
Current EBITDA COMPUTED$-101K
Operating Margin COMPUTED-1.6%
Occupancy HCRIS36.1%
Revenue / Bed COMPUTED$261K
Net-to-Gross HCRIS43.9%
Distress Probability ML61.7%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
77
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -1.6% places it below the state median. Among 77 size-comparable peers (12-48 beds), the median margin is -1.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-48), prioritizing same-state peers. 77 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SPECIALTY HOSPITAL OF LORAIN (Target)OH24$6.3M-1.6%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
GALION COMMUNITY HOSPITALOH25$128.2M16.6%
MARY RUTAN HOSPITALOH39$113.0M-12.5%
MERCY HEALTH-TIFFIN HOSPITAL OH35$103.0M18.1%
JOINT TOWNSHIP DISTRICT MEMORIOH33$95.6M9.3%
FULTON COUNTY HEALTH CENTEROH25$95.2M-7.4%
UH SAMARITAN MEDICAL CENTEROH39$88.9M-3.5%
MERCER COUNTY COMMUNITY HOSPITOH42$87.8M-0.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $472K (753bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$132K+210bp18mo
Denial Rate Reduction12.0%6.5%$129K+206bp12mo
Cost to Collect4.5%2.5%$125K+200bp12mo
A/R Days Reduction5200.0%3800.0%$76K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+15bp6mo

5. EBITDA Bridge

Net Collection Rate
$132K
Denial Rate Reduction
$129K
Cost to Collect
$125K
A/R Days Reduction
$76K
Clean Claim Rate
$10K
Total EBITDA Uplift$472K
Current EBITDA$-101K
+ RCM Uplift+$472K
Pro Forma EBITDA$370K
Current Margin-1.6%
Pro Forma Margin5.9%
WC Released (1x)$240K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-156K$4.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-156K$4.4M0.00x-100.0%
Bull Case9.0x11.0x$-140K$5.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-140K$6.4M0.00x-100.0%
Bear Case11.0x10.0x$-172K$1.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-172K$1.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (32.6%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 61.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 77 hospitals with 12-48 beds
  • Same-state prioritization (n=78)
  • Comp margins: P25=-11.5% / P50=-1.9% / P75=11.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.